Terlipressin | List of Frontiers open access articles

Original Research

Published on 07 Oct 2022

Improvement of gut-vascular barrier by terlipressin reduces bacterial translocation and remote organ injuries in gut-derived sepsis

in Gastrointestinal and Hepatic Pharmacology

Zenan Chang
Yinan Zhang
Ming Lin
Shihong Wen
Hanjin Lai
Yaqing Zhan
Xiufen Zhu
Zhikun Huang
Xuyu Zhang
Zimeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1019109

5,401 views
11 citations

Original Research

Published on 01 Oct 2021

Effects of Terlipressin on Management of Hypotensive Brain-Dead Patients Who are Potential Organ Donors: A Retrospective Study

in Renal Pharmacology

Donghua Zheng
Genglong Liu
Li Chen
Wenfeng Xie
Jiaqi Sun
Siqi Wang
Qiang Tai

Frontiers in Pharmacology

doi 10.3389/fphar.2021.716759

2,985 views
2 citations

Systematic Review

Published on 04 Sep 2024

Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis

in Renal Pharmacology

Yue-Meng Wan
Song-Quan Huang
Hua-Mei Wu
Yu-Hua Li
Hong-Jing Yin
Ying Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418826

3,636 views
3 citations

Systematic Review

Published on 23 Dec 2019

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis

in Drugs Outcomes Research and Policies

Po Huang
Yuhong Guo
Bo Li
Qingquan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01492

8,535 views
16 citations

Clinical Trial

Published on 02 Jul 2021

Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial

in Gastrointestinal and Hepatic Pharmacology

Eman Ibrahim El-Desoki Mahmoud
Doaa H Abdelaziz
Sherief Abd-Elsalam
Noha O. Mansour

Frontiers in Pharmacology

doi 10.3389/fphar.2021.675948

18,236 views
34 citations

Review

Published on 17 Nov 2022

Volume and flow modulation strategies to mitigate post-hepatectomy liver failure

in Surgical Oncology

Richard Bell
Saleema Begum
Raj Prasad
Kojiro Taura
Bobby V. M. Dasari

Frontiers in Oncology

doi 10.3389/fonc.2022.1021018

5,386 views
11 citations

Original Research

Published on 31 Jan 2020

Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome

in Renal Pharmacology

Ahmed Abdel-Razik
Nasser Mousa
Mostafa Abdelsalam
Ahmed Abdelwahab
Mona Tawfik
Ahmed M. Tawfik
Ahmad S. Hasan
Rania Elhelaly
Niveen El-Wakeel
Waleed Eldars

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00009

4,167 views
10 citations

Articles

Improvement of gut-vascular barrier by terlipressin reduces bacterial translocation and remote organ injuries in gut-derived sepsis

Effects of Terlipressin on Management of Hypotensive Brain-Dead Patients Who are Potential Organ Donors: A Retrospective Study

Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis

Norepinephrine is More Effective Than Midodrine/Octreotide in Patients With Hepatorenal Syndrome-Acute Kidney Injury: A Randomized Controlled Trial

Volume and flow modulation strategies to mitigate post-hepatectomy liver failure

Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome